Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inozyme Pharma

3.99
0.0000
Post-market: 3.98-0.0050-0.13%16:35 EDT
Volume:698.56K
Turnover:2.78M
Market Cap:258.69M
PE:-2.37
High:3.99
Open:3.98
Low:3.98
Close:3.99
Loading ...

Wedbush Downgrades Inozyme Pharma to Neutral From Outperform, Adjusts Price Target to $4 From $7

MT Newswires Live
·
16 May

BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, Charter Communications, Vistra

Reuters
·
16 May

BUZZ-Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin

Reuters
·
16 May

Inozyme Pharma Shares Nearly Triple to $3.96 Premarket After Biomarin to Buy Co for $270 Mln

THOMSON REUTERS
·
16 May

BioMarin Acquires Inozyme Pharma for $270 Million

TIPRANKS
·
16 May

BioMarin Pharmaceutical to Acquire Inozyme Pharma for $270 Million

MT Newswires Live
·
16 May

BRIEF-Biomarin To Acquire Inozyme Pharma

Reuters
·
16 May

BioMarin to acquire Inozyme for $4.00 per share in cash, or $270M

TIPRANKS
·
16 May

Inozyme Pharma Inc - Biomarin to Buy Inozyme for $270 Mln

THOMSON REUTERS
·
16 May

Biomarin Strengthens Enzyme Therapy Business With Acquisition of Inozyme Pharma

THOMSON REUTERS
·
16 May

Inozyme Pharma Is Maintained at Buy by Needham

Dow Jones
·
15 May

Inozyme Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Inozyme Pharma Q1 EPS $(0.44) Misses $(0.41) Estimate

Benzinga
·
14 May

Inozyme Pharma Reports Increased R&D Expenses and Cash Position, No Sales or Net Income Data Released for Q1 2025

Reuters
·
14 May

Inozyme Pharma Inc: Restructuring Charges Were $1.9 Mln for Quarter Ended March 31, 2025

THOMSON REUTERS
·
14 May

Inozyme Pharma Inc: Reduced Workforce by About 25% Across All Areas of Company During the Qtr

THOMSON REUTERS
·
14 May

Inozyme Pharma Q1 EPS USD -0.44

THOMSON REUTERS
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Inozyme Pharma Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
02 May

Inozyme Pharma Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Apr